Elina Nummenmaa

422 total citations
16 papers, 341 citations indexed

About

Elina Nummenmaa is a scholar working on Sensory Systems, Cellular and Molecular Neuroscience and Molecular Biology. According to data from OpenAlex, Elina Nummenmaa has authored 16 papers receiving a total of 341 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Sensory Systems, 5 papers in Cellular and Molecular Neuroscience and 3 papers in Molecular Biology. Recurrent topics in Elina Nummenmaa's work include Ion Channels and Receptors (9 papers), Neurobiology and Insect Physiology Research (5 papers) and Osteoarthritis Treatment and Mechanisms (3 papers). Elina Nummenmaa is often cited by papers focused on Ion Channels and Receptors (9 papers), Neurobiology and Insect Physiology Research (5 papers) and Osteoarthritis Treatment and Mechanisms (3 papers). Elina Nummenmaa collaborates with scholars based in Finland and Netherlands. Elina Nummenmaa's co-authors include Mari Hämäläinen, Eeva Moilanen, Katriina Vuolteenaho, Teemu Moilanen, Lauri Moilanen, R. Nieminen, Pinja Ilmarinen, Lauri Lehtimäki, Riina Nieminen and Erja‐Leena Paukkeri and has published in prestigious journals such as PLoS ONE, International Journal of Molecular Sciences and Osteoarthritis and Cartilage.

In The Last Decade

Elina Nummenmaa

16 papers receiving 338 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Elina Nummenmaa Finland 9 121 116 90 59 49 16 341
Mélanie Gabriac France 7 129 1.1× 64 0.6× 51 0.6× 108 1.8× 39 0.8× 9 389
Jin Dai China 12 224 1.9× 108 0.9× 110 1.2× 23 0.4× 40 0.8× 28 476
Yong Won Choi South Korea 9 141 1.2× 60 0.5× 47 0.5× 26 0.4× 41 0.8× 30 389
Ichiro Hikita Japan 11 97 0.8× 200 1.7× 70 0.8× 123 2.1× 30 0.6× 12 787
Masayori Kagoura Japan 11 84 0.7× 24 0.2× 96 1.1× 108 1.8× 51 1.0× 28 645
Gabriela Kukova Germany 7 63 0.5× 92 0.8× 147 1.6× 198 3.4× 20 0.4× 13 787
Miyoung Park South Korea 11 81 0.7× 60 0.5× 20 0.2× 37 0.6× 17 0.3× 19 409
Hiromi Kanto Japan 12 106 0.9× 74 0.6× 15 0.2× 25 0.4× 34 0.7× 25 684
Ji‐Hae Lee South Korea 12 135 1.1× 30 0.3× 16 0.2× 38 0.6× 80 1.6× 47 419
Mathias Sulk Germany 9 50 0.4× 93 0.8× 103 1.1× 69 1.2× 13 0.3× 17 993

Countries citing papers authored by Elina Nummenmaa

Since Specialization
Citations

This map shows the geographic impact of Elina Nummenmaa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elina Nummenmaa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elina Nummenmaa more than expected).

Fields of papers citing papers by Elina Nummenmaa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elina Nummenmaa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elina Nummenmaa. The network helps show where Elina Nummenmaa may publish in the future.

Co-authorship network of co-authors of Elina Nummenmaa

This figure shows the co-authorship network connecting the top 25 collaborators of Elina Nummenmaa. A scholar is included among the top collaborators of Elina Nummenmaa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elina Nummenmaa. Elina Nummenmaa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Nummenmaa, Elina, et al.. (2024). The glucocorticoid dexamethasone alleviates allergic inflammation through a mitogen‐activated protein kinase phosphatase‐1‐dependent mechanism in mice. Basic & Clinical Pharmacology & Toxicology. 134(5). 686–694. 3 indexed citations
2.
Nummenmaa, Elina, et al.. (2023). Human Osteoarthritic Chondrocytes Express Nineteen Different TRP-Genes—TRPA1 and TRPM8 as Potential Drug Targets. International Journal of Molecular Sciences. 24(12). 10057–10057. 14 indexed citations
3.
Nummenmaa, Elina, et al.. (2022). Dexamethasone Attenuates the Expression of MMP-13 in Chondrocytes through MKP-1. International Journal of Molecular Sciences. 23(7). 3880–3880. 5 indexed citations
4.
Nummenmaa, Elina. (2020). TRPA1 as a Novel Factor and Drug Target in Osteoarthritis. Tampere University Institutional Repository (Tampere University). 1 indexed citations
5.
Nummenmaa, Elina, Mari Hämäläinen, Lauri Moilanen, et al.. (2020). Transient Receptor Potential Ankyrin 1 (TRPA1) Is Involved in Upregulating Interleukin-6 Expression in Osteoarthritic Chondrocyte Models. International Journal of Molecular Sciences. 22(1). 87–87. 26 indexed citations
6.
Nummenmaa, Elina, Mari Hämäläinen, Lauri Moilanen, et al.. (2019). Transient receptor potential ankyrin 1 (TRPA1) as a factor and drug target in osteoarthritis: TRPA1 mediates fibroblast growth factor 2 expression in chondrocytes. Osteoarthritis and Cartilage. 27. S377–S377. 2 indexed citations
7.
Hämäläinen, Mari, et al.. (2019). Downregulation of microsomal prostaglandin E synthase-1 (mPGES-1) expression in chondrocytes is regulated by MAP kinase phosphatase-1 (MKP-1). International Immunopharmacology. 71. 139–143. 8 indexed citations
8.
Nummenmaa, Elina, Mari Hämäläinen, Lauri Moilanen, et al.. (2018). TRPA1 as a factor and drug target in osteoarthritis: TRPA1 (transient receptor potential ankyrin 1) mediates interleukin-6 expression in chondrocytes. Osteoarthritis and Cartilage. 26. S124–S124. 2 indexed citations
9.
Nummenmaa, Elina, Mari Hämäläinen, Lauri Moilanen, et al.. (2017). TRPA1 expression is downregulated by dexamethasone and aurothiomalate in human chondrocytes: TRPA1 as a novel factor and drug target in arthritis. RMD Open. 3(2). e000556–e000556. 9 indexed citations
10.
Nummenmaa, Elina, Mari Hämäläinen, Lauri Moilanen, et al.. (2016). Transient receptor potential ankyrin 1 (TRPA1) is functionally expressed in primary human osteoarthritic chondrocytes. Arthritis Research & Therapy. 18(1). 185–185. 50 indexed citations
11.
Nummenmaa, Elina, Mari Hämäläinen, Lauri Moilanen, et al.. (2016). Transient receptor potential ankyrin 1 (TRPA1) is functionally expressed in primary human osteoarthritic chondrocytes. Osteoarthritis and Cartilage. 24. S329–S329. 25 indexed citations
12.
Moilanen, Lauri, Mari Hämäläinen, Elina Nummenmaa, et al.. (2015). Monosodium iodoacetate-induced inflammation and joint pain are reduced in TRPA1 deficient mice – potential role of TRPA1 in osteoarthritis. Osteoarthritis and Cartilage. 23(11). 2017–2026. 86 indexed citations
13.
Nummenmaa, Elina, Mari Hämäläinen, Teemu Moilanen, Katriina Vuolteenaho, & Eeva Moilanen. (2015). Effects of FGF-2 and FGF receptor antagonists on MMP enzymes, aggrecan, and type II collagen in primary human OA chondrocytes. Scandinavian Journal of Rheumatology. 44(4). 321–330. 51 indexed citations
14.
Moilanen, Lauri, Mari Hämäläinen, Elina Nummenmaa, et al.. (2015). MIA-induced inflammation and joint pain are reduced in TRPA1 deficient mice – Potential role for trpa1 in osteoarthritis. Osteoarthritis and Cartilage. 23. A259–A259. 1 indexed citations
15.
Nummenmaa, Elina, Mari Hämäläinen, Teemu Moilanen, Katriina Vuolteenaho, & Eeva Moilanen. (2015). Effects of fibroblast growth factor-2 and its receptor antagonists in osteoarthritis. Osteoarthritis and Cartilage. 23. A269–A269. 1 indexed citations
16.
Ossowski, Ingemar von, Taija E. Pietilä, Johanna Rintahaka, et al.. (2013). Using Recombinant Lactococci as an Approach to Dissect the Immunomodulating Capacity of Surface Piliation in Probiotic Lactobacillus rhamnosus GG. PLoS ONE. 8(5). e64416–e64416. 57 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026